Altimmune Mergers and Acquisitions Summary

Life Science Company

Altimmune has acquired 2 companies. A total of 1 acquisition came from private equity firms.

Altimmune has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include healthcare services (50%) and life science (50%).

Join Mergr and gain access to Altimmune’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 2

Altimmune, Inc.

910 Clopper Road, Suite 201S,
Gaithersburg, Maryland 20878
United States,
(240) 654-1450
www.altimmune.com

Altimmune, Inc. is an operator of clinical stage biotechnology company developing next-generation immunotherapeutics and vaccines to address significant public health and biodefense needs. By leveraging specific attributes of its two independent and complementary platform technologies, Altimmune rapidly designs product candidates against a wide range of disease targets, including respiratory diseases, chronic infections, and cancer. Altimmune was founded in 1997 and is based in Gaithersburg, Alabama.


M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (0.0/yr) # 2 - - - - - 2
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
Immune Targeting Systems Ltd. 2015-02-17 - Add-on Acquisition
London, United Kingdom
Avecia - Biodefense vaccines Business 2008-03-24 - Divestiture
, United States
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Healthcare Services 1 (50%) - - -
Life Science 1 (50%) - - -
Total 2 - - -

By Geo

State/Country Buy Value Sell Value
United Kingdom 1 - - -
United States 1 - - -
Domestic 1 (50%) - - -
Cross-border 1 (50%) - - -
Total 2 - - -

M&A Connections

Deals
Acquired from
Investor(s)
50%
1 (50%)
Strategic(s)
50%
1 (50%)

Company Summary

SECTOR

Life Science

Revenue

6   40% 2019
10   10% 2018
11   120% 2017
5   55% 2016
11   10% 2015
10   45% 2014
18   28% 2013
25   2012
(millions of USD) Show More Show Less

Employees

27

Established

1997

Public

NASDAQ: ALT

Former Name

Vaxin, Inc.

 Subscribe to unlock this and 159,859
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.1K Private Equity Firms
  • 148K M&A Transactions
  • 156K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.2K M&A Advisors
    (Investment Banks and Law Firms)
  • 47K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal